Afuco™ Anti-Human GHR ADCC Theraputic Antibody, ADCC Enhanced
Product Quick Detail
- Minimum Order
- 1
- Place Of Origin
- USA
- Packaging
- N/A
- Delivery
- 15 Days
Specifications
Anti-GHR ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies binding to human growth hormone receptor (GHR) can be used therapeutically to lower
IGF-1 levels in plasma and/or tissue, and can be used in the prevention and/or treatment of cancer, diabetic nephropathy, arthritis, lung inflammation, and growth disorders, including acromegaly and
gigantism.
https://www.creativebiolabs.net/Anti-GHR-ADCC-Enhanced-Antibody-20604.htm
- Country: United States
- Business Type:
- Market:
- Founded Year:2005
- Address:
- Contact:Jerry Carter
Other products from Creative Biolabs
Relate products of Afuco™ Anti-Human GHR ADCC Theraputic Antibody, ADCC Enhanced
Afuco™ Anti-Human GM1 ADCC Theraputic Antibody, ADCC Enhanced
Anti-GM1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The monoclonal antibodies that specifically bind to Fucosyl-GM1 with high affinity are used for detecting Fucosyl-GM1, as well as treating various diseases, including cancer. ...
Afuco™ Anti-Human CSF1 ADCC Theraputic Antibody (PD-0360324), ADCC Enhanced
Anti-CSF1 ADCC Enhanced Antibody (PD-0360324) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a novel neutralizing human monoclonal antibody against monocyte/ macrophage colony stimulating factor (M-CSF). It exhibited a nonlinear PK profile associated ...
